Efficacy and tolerability of mirtazapine in patients with post-myocardial infarction depression in the Myocardial Infarction and Depression-Intervention Trial (MIND-IT)

Trial Profile

Efficacy and tolerability of mirtazapine in patients with post-myocardial infarction depression in the Myocardial Infarction and Depression-Intervention Trial (MIND-IT)

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Sep 2015

At a glance

  • Drugs Citalopram; Mirtazapine
  • Indications Cardiovascular disorders; Depression
  • Focus Therapeutic Use
  • Acronyms MIND-IT
  • Most Recent Events

    • 24 May 2012 New source identifed and integrated (ISRCTN: Current Controlled Trials record.)
    • 01 Feb 2011 Substudy results published in the Neuropsychobiology.
    • 05 Nov 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top